Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2025-12-30 @ 2:42 PM
Study NCT ID:
NCT02585804
Status:
COMPLETED
Last Update Posted:
2018-01-16
First Post:
2015-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects
Sponsor:
University Health Network, Toronto
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09
Start Date Type:
None
Primary Completion Date:
2017-04-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04-24
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-22
First Submit QC Date:
None
Study First Post Date:
2015-10-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-11
Last Update Post Date:
2018-01-16
Last Update Post Date Type:
ACTUAL